Lipocalin 2 is essential for chronic kidney disease progression in mice and humans

Lipocalin 2-Dependent Inhibition of Mycobacterial Growth in Alveolar Epithelium

(2014) H. Saiga et al.   JOURNAL OF IMMUNOLOGY

Lipocalin 2: A multifaceted modulator of human cancer

(2011) Jiang Yang et al.   CELL CYCLE

Effects of Increased Renal Tubular Vascular Endothelial Growth Factor (VEGF) on Fibrosis, Cyst Formation, and Glomerular Disease

(2009) Samy Hakroush et al.   AMERICAN JOURNAL OF PATHOLOGY

Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

(2009) X. Leng et al.   CANCER RESEARCH

Lipocalin signaling controls unicellular tube development in the Caenorhabditis elegans excretory system

(2009) Craig E. Stone et al.   DEVELOPMENTAL BIOLOGY

HIF in Kidney Disease and Development

(2009) L. Gunaratnam et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy

(2009) N. Paragas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons

(2009) Takashige Kuwabara et al.   KIDNEY INTERNATIONAL

The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology

(2008) Fenghua Zeng et al.   EXPERIMENTAL CELL RESEARCH

Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family

(2008) H. Michael Shepard et al.   JOURNAL OF CLINICAL INVESTIGATION

Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo

(2008) Feng Wei et al.   KIDNEY INTERNATIONAL

Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics

(2008) Leon G. Fine et al.   KIDNEY INTERNATIONAL